Evidence map›Paper›PMID 26689982›Full record

ArticleJournal of extracellular vesicles2015

Microvesicle phenotypes are associated with transfusion requirements and mortality in subjects with severe injuries.

Nena Matijevic, Yao-Wei W Wang, John B Holcomb, Rosemary Kozar, Jessica C Cardenas, Charles E Wade

Open access · goldAbstract read
In one paragraph

Article in Journal of extracellular vesicles, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Innate immune responses to trauma.Nature immunology · 2018
    Review
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nena MatijevicDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Yao-Wei W WangThe Center for Translational Injury Research, The University of Texas Health Science Center at Houston, Houston, TX, USA.
John B HolcombDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Rosemary KozarDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Jessica C CardenasDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Charles E WadeDepartment of Surgery, The University of Texas Health Science Center at Houston, Houston, TX, USA.
The University of Texas Health Science Center at Houston · US

Funding

SUMS)P50GM038529 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI HOLCOMB, JOHN B · 1988 to 2008
$11.7M
ROLE OF THE GUT IN POST INJURY MULTIPLE ORGAN FAILURET32GM008792 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI Charles S Cox · 2001 to 2026
$5.2M
Role of GPIba Receptor Shedding in Platelet Dysfunction Following TraumaF32HL120549 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CARDENAS, JESSICA · 2014 to 2015
$81k
NHLBI NIH HHS F32 HL120549NIGMS NIH HHS P50 GM038529NIGMS NIH HHS T32 GM008792
6 · The paper itself

Abstract

backgroundSevere injury often results in substantial bleeding and mortality. Injury provokes cellular activation and release of extracellular vesicles. Circulating microvesicles (MVs) are predominantly platelet-derived and highly procoagulant. They support hemostasis and vascular function. The roles of MVs in survival after severe injury are largely unknown. We hypothesized that altered MV phenotypes would be associated with transfusion requirements and poor outcomes.

methodsThis single-centre study was approved by the Institutional Review Board. The study cohort consisted of patients with major trauma requiring blood product transfusion and 26 healthy controls. Plasma samples for MVs were collected upon admission to the emergency department (n=169) and post-resuscitation (n=42), and analysed by flow cytometry for MV counts and cellular origin: platelet (PMV), erythrocyte (RMV), leukocyte (LMV), endothelial (EMV), tissue factor (TFMV), and annexin V (AVMV). Twenty-four hour mortality is the outcome measurement used to classify survivors versus non-survivors. Data were compared over time and analysed with demographic and clinical data.

resultsThe median age was 34 (IQR 23, 51), 72% were male, Injury Severity Score was 29 (IQR 19, 36), and 24 h mortality was 13%. MV levels and phenotypes differed between patients and controls. Elevated admission EMVs were found both in survivors (409/µL) and non-survivors (393/µL) compared to controls (23/µL, p<0.001) and persisted over time. Admission levels of PMV, AVMV, RMV, and TFMV were significantly lower in patients who died compared to survivors, but were not independently associated with the 24 h mortality rate. Patients with low MV levels at admission received the most blood products within the first 24 h. AVMV and PMV levels either increased over time or stabilized in survivors but decreased in non-survivors, resulting in significantly lower levels at intensive care unit admission in non-survivors (1,048 vs. 1,880 AVMV/µL, p<0.00004 and 1,245 PMP/µL vs. 1,866 PMP/µL, p=0.003).

conclusionSevere injury results in endothelial activation and altered MV phenotypes. Significant differences in specific MV phenotypes or changes over time were associated with blood product requirements and the 24 h mortality rate.

Indexed as

coagulopathyextracellular vesiclesinjurymicroparticlesmicrovesiclestransfusionstrauma

Identifiers

PMID26689982
PMCPMC4685295
OpenAlexW2209594603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.